EMA CHMP provides positive opinion for Janssen’s multiple myeloma therapy

CARVYKTI marks the first CAR-T therapy to receive a positive CHMP opinion for multiple myeloma patients after just one relapse. Credit: Colin Behrens from Pixabay.